Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
19 nov. 2024 17h00 HE
|
Cytek Biosciences, Inc.
Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual BioTech Breakthrough Awards program.
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
07 nov. 2024 17h00 HE
|
Cytek Biosciences, Inc.
Cytek has introduced the world’s first Enhanced Small Particle (ESP™) Detection Sorter, which opens the door to scientific discoveries.
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
18 sept. 2024 17h00 HE
|
Cytek Biosciences, Inc.
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
Global Single-cell Analysis Market Analysis Report 2024-2030, by Product (Consumables, Instruments), Application (Cancer, Stem Cell), Workflow (Downstream Analysis, Data Analysis), End-use and Region
11 juin 2024 11h19 HE
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Global Single-cell Analysis Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Application (Cancer, Stem Cell),...
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
28 mai 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received China NMPA approval for for clinical diagnostic use.
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
20 mai 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek has announced its Enhanced Small Particle Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
07 mars 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek Biosciences has opened a 50,000-square-foot facility in Wuxi, China to meet the growing worldwide demand for comprehensive cell analysis solutions
Asia-Pacific Functional Genomics Market Report 2023-2033: Country-Level Insights for Gene Therapy, Drug Discovery & Development, Gene Expression, and Single-Cell Analysis
30 janv. 2024 10h42 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Functional Genomics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.As of 2023, the...
Single Cell Genomics and Proteomics in the United States: Public Funding and Large Biopharma Investments Support Technological Advancements and Improved Analysis
19 janv. 2024 07h23 HE
|
Research and Markets
Dublin, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Single Cell Genomics and Proteomics in the United States" report has been added to ResearchAndMarkets.com's offering. In...
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
17 janv. 2024 17h30 HE
|
Cytek Biosciences, Inc.
Cytek Biosciences has signed an agreement with The Centre for Genomic Regulation and the Pompeu Fabra University to accelerate scientific discoveries.